FirstWord

At the midpoint of its proposed offering, Iambic would raise $150 million.

The life sciences supplier plans to link AI, robotics and lab instruments at its Abcam unit to speed the design and testing of antibodies and other affinity reagents.

Zuckerberg's Biohub is combining new cell data with federal datasets to train AI models that can predict how cells respond to changes, helping researchers study disease and identify potential treatments.

The new approach could spare patients from undergoing invasive biopsies.

The French biotech will use PacBio's HiFi and Kinnex long-read RNA sequencing to generate data from over 10,000 samples.

BRANFORD, Conn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecul...

Inaugural competition will connect emerging AI life sciences platforms with validation expertise, investors, and ecosystem partners during JPM WeekApplications are now open for the GenScript and NVIDI...

Briya AIRE's analysis of 28,795 abdominal ultrasound reports found 78% of steatotic liver patients were identified only through unstructured radiology reportsNEW YORK, Oct. 8, 2026 /PRNewswire/ -- Bri...

Company highlights next-generation augmented reality navigation and spinal fixation technologies ahead of broader commercial launchesNEW YORK--(BUSINESS WIRE)--VB Spine LLC (“VB Spine”), the largest p...

American Heart Association Hypertension Scientific Sessions 2026 – Moderated Poster #TH125Research Highlights:Three of the top four popular artificial intelligence (AI) tools – OpenAI’s ChatGPT, Micro...